Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

Read the entire article at: https://openheart.bmj.com/content/9/1/e001989

Myo-inositol should be considered in patients with insulin resistance, metabolic syndrome, type 1 diabetes, type 2 diabetes, PCOS and those with or at risk of gestational diabetes. Elevated levels of glucose reduce myo-inositol levels in tissues and increase its breakdown and elimination via the kidneys. Myo-inositol has been used safely for decades in many studies in those with insulin resistance and PCOS.